Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis
Author(s) -
David M. Stepien,
Charles Hwang,
Simone Marini,
Chase A. Pagani,
Michael Sorkin,
Noelle D. Visser,
Amanda K. Huber,
Nicole Edwards,
Shawn Loder,
Kaetlin Vasquez,
Carlos A. Aguilar,
Ravi Kumar,
Shamik Mascharak,
Michael T. Longaker,
Jun Z. Li,
Benjamin Levi
Publication year - 2020
Publication title -
the journal of immunology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1900814
Subject(s) - fibrosis , cardiotoxin , regeneration (biology) , skeletal muscle , myeloid , progenitor cell , medicine , cancer research , immunology , biology , microbiology and biotechnology , pathology , stem cell
Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell-derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom